Fludrocortisone in the treatment of systemic hypotension in primary open-angle glaucoma patients

International Ophthalmology

Volumn 23, Issue 1, 1999, Pages 25-30

  Gugleta, Konstantin ^a   Orgül, Selim ^a   Stümpfig, Daniela ^a   Dubler, Barbara ^a   Flammer, Josef ^a  

^a UNIVERSITY EYE CLINIC   (Switzerland)

Author keywords

Fludrocortisone; Glaucoma; Systemic hypotension

Indexed keywords

FLUDROCORTISONE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HYPOTENSION; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; RETROSPECTIVE STUDY;

BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; FEMALE; FLUDROCORTISONE; GLAUCOMA, OPEN-ANGLE; HUMANS; HYPOTENSION; INTRAOCULAR PRESSURE; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; MINERALOCORTICOIDS; RETROSPECTIVE STUDIES; VIDEO RECORDING;

EID: 0033303880     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006434231844     Document Type: Article

References (35)

1. Optic nerve blood-flow abnormalities in glaucoma
2. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects
3. Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma)
4. Unequal intraocular pressure and its relation to asymmetric visual field defects in low-tension glaucoma
5. Relationship between asymmetry of visual field defects and intraocular pressure difference in an untreated normal (low) tension glaucoma population
6. Interocular visual-field and intraocular pressure asymmetries in normal-tension glaucoma
7. Blood-cell velocity in the nailfold capillaries of patients with normal-tension and high-tension glaucoma
8. Systemic hypotension: A risk factor for glaucomatous damage?
9. Systemic blood pressure in glaucoma patients
10. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders
11. The influence of magnesium of visual field and peripheral vasospasm in glaucoma
12. Systemic calcium channel blockers and glaucoma
13. The effect of calcium antagonists on visual field in low-tension glaucoma
14. Lack of effect of calcium channel blockers on open-angle glaucoma
15. Calcium channel blockers in the management of low-tension and open-angle glaucoma
16. Color Doppler ultrasound analysis of ocular circulation after topical calcium channel blocker
17. The nerve of glaucoma!
18. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma
19. Hemodynamic and visual function effects of oral nifedipine in patients with primary open-angle glaucoma
20. Clinical factors associated with progression of normal-tension glaucoma
21. Hypertension, perfusion pressure, and primary open-angle glaucoma. A Population-based Assessment
22. The probable involvement of factors other than ocular pressure in the pathogenesis of glaucoma
23. Clinical syndromes with vasoconstrictor response
24. Therapeutical aspects of normal-tension glaucoma
25. Blockage of axonal transport in optic nerve induced by elevation of intraocular pressure. Effect of arterial hypertension induced by angiotensin I
26. Fludrocortisone in the treatment of hypotensive disorders in the elderly
27. Recent advances in the treatment of orthostatic hypotension
28. Management of orthostatic hypotension
29. Silent myocardial ischemia in glaucoma patients
30. Inverse correlation between endothelin-1-induced peripheral microvascular vasoconstriction and blood pressure in glaucoma patient
31. Systemic blood pressure and capillary blood-cell velocity in glaucoma patients. A preliminary study
32. Endothelium derived vasoactive substances relevant for normal-tension glaucoma
33. Idiopathic orthostatic hypotension
34. Successful treatment of orthostatic hypotension with 9-alpha fluorohydrocortisone
35. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome